Overview
Does Icodextrin Reduce the Risk of Small Bowel Obstruction?
Status:
Active, not recruiting
Active, not recruiting
Trial end date:
2022-12-01
2022-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study aims at investigating if icodextrin 4% instilled in abdominal cavity during surgery can reduce the risk of surgery and hospitalisation for small bowel obstruction in patients with colorectal cancer. Follow-up data is collected from the Swedish national colorectal cancer registry.Patients are followed for 5 years postoperatively.The study is a randomized Swedish multicenter study and planned to include 1,800 patients. A safety control is planned after 300 included patients.Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Uppsala UniversityTreatments:
Icodextrin
Criteria
Inclusion Criteria:- Colorectal cancer
- Curative surgery planned
- Informed consent
- Age 18-85
Exclusion Criteria:
- Local surgery planned
- Generalized disease
- Other malignancy
- Not informed consent